O
QURE icon

OrbiMed’s uniQure QURE Stock Holding History

OrbiMed’s Portfolio QURE Stock Details QURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.3M Sell
1,807,486
-328,663
-15% -$8.6M 1.54% 14
2026
Q1 		$34.9M Buy
2,136,149
+1,398,749
+190% +$28.3M 0.69% 43
2025
Q4 		$17.6M Buy
737,400
+278,900
+61% +$10.8M 0.36% 65
2025
Q3 		$26.8M Buy
+458,500
New +$8.32M 0.63% 47
2024
Q1 		– Sell
-1,347,900
Closed -$9.13M – 123
2023
Q4 		$9.13M Sell
1,347,900
-716,555
-35% -$4.74M 0.18% 79
2023
Q3 		$13.9M Hold
2,064,455
– – 0.29% 70
2023
Q2 		$23.7M Hold
2,064,455
– – 0.43% 65
2023
Q1 		$41.6M Buy
2,064,455
+316,900
+18% +$6.65M 0.82% 41
2022
Q4 		$39.6M Buy
1,747,555
+150,555
+9% +$3.25M 0.76% 49
2022
Q3 		$30M Buy
1,597,000
+722,151
+83% +$15.2M 0.56% 59
2022
Q2 		$16.3M Sell
874,849
-44,400
-5% -$706K 0.3% 71
2022
Q1 		$16.6M Buy
919,249
+333,675
+57% +$5.83M 0.27% 74
2021
Q4 		$12.1M Hold
585,574
– – 0.16% 111
2021
Q3 		$18.7M Buy
585,574
+114,400
+24% +$3.49M 0.21% 98
2021
Q2 		$14.5M Sell
471,174
-497,905
-51% -$16.7M 0.15% 109
2021
Q1 		$32.6M Hold
969,079
– – 0.31% 77
2020
Q4 		$35M Hold
969,079
– – 0.31% 77
2020
Q3 		$35.7M Hold
969,079
– – 0.45% 61
2020
Q2 		$43.7M Sell
969,079
-14,900
-2% -$880K 0.61% 52
2020
Q1 		$46.7M Sell
983,979
-97,786
-9% -$5.62M 0.78% 41
2019
Q4 		$77.5M Buy
1,081,765
+242,165
+29% +$13.3M 1.11% 34
2019
Q3 		$33M Sell
839,600
-58,200
-6% -$3.36M 0.63% 48
2019
Q2 		$70.2M Buy
+897,800
New +$57.2M 1.09% 30
2016
Q4 		– Sell
-489,000
Closed -$3.74M – 138
2016
Q3 		$3.74M Buy
489,000
+293,600
+150% +$2.33M 0.04% 122
2016
Q2 		$1.44M Buy
195,400
+10,600
+6% +$127K 0.02% 123
2016
Q1 		$2.19M Buy
+184,800
New +$2.73M 0.02% 128

Other funds holding QURE

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OrbiMed's QURE Position: Q2 2026 in Review

OrbiMed reduced its uniQure (QURE) stake by 15% in Q2 2026, selling an estimated $8.6M and leaving 1,807,486 shares worth $83.3M. The position accounts for 1.54% of the portfolio, ranked #14.

OrbiMed first reported a position in QURE in Q1 2016 and has held it in 26 quarters since. 254 funds tracked by Wall St. Rank hold QURE as of Q2 2026.

  • OrbiMed held 1,807,486 shares of uniQure worth $83.3M as of Q2 2026.
  • OrbiMed sold 328,663 uniQure shares in Q2 2026, an estimated $8.6M.
  • uniQure made up 1.54% of OrbiMed's portfolio in Q2 2026, its #14 holding.
  • OrbiMed first reported a position in uniQure in Q1 2016 and has held it in 26 quarters since.
  • 254 funds tracked by Wall St. Rank held uniQure as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.